DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Lenz HJ, Mayer RJ, Gold PJ. et al.
Activity of cetuximab in patients with colorectal cancer refractory to both irinotecan and oxaliplatin.
JCO 2004; 22: 3510-
We do not assume any responsibility for the contents of the web pages of other providers.